RT Journal Article
SR Electronic
A1 Coltrera, Francesca
T1 Platinum-Plus Regimens Equally Effective First Therapies for EGFR Wild-Type NSCLC
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 8
SP 18
OP 18
DO 10.1177/1559897715588049
UL http://mdc.sagepub.com/content/15/8/18.1.abstract
AB In a single-site, retrospective study comparing the efficacy of several platinum doublet regimens in patients with EGFR wild-type, nonsquamous non–small cell lung cancer, no differences were found in overall survival or response rate between platinum plus pemetrexed or nonpemetrexed therapies (eg, gemcitabine, taxanes).